Exercise treadmill - Hemispherx Comments on Chronic Fatigue Syndrome Initiatives by

Hemispherx Comments on Chronic Fatigue Syndrome Initiatives by
MSN MoneyCentral - In the completed Phase 3 trial, patients receiving Ampligen(R) for 40 weeks improved exercise treadmill performance 14.8% in the placebo group (p=0.025) and 13% by intent to treat analysis (p=0.052). The Ampligen group improved oxygen
Source: news.moneycentral.msn.com